These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 2884549

  • 21. [Implications of GABAergic synapses in neuropsychiatry].
    Lloyd KG, Perrault G, Zivkovic B.
    J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
    [Abstract] [Full Text] [Related]

  • 22. The GABA-ergic system: a locus of benzodiazepine action.
    Tallman JF, Gallager DW.
    Annu Rev Neurosci; 1985; 8():21-44. PubMed ID: 2858999
    [No Abstract] [Full Text] [Related]

  • 23. The present status of benzodiazepines in psychopharmacology.
    Iversen LL.
    Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495
    [Abstract] [Full Text] [Related]

  • 24. [GABA and anxiety].
    Guelfi JD, Waintraub L.
    Encephale; 1987 Jul; 13 Spec No():211-4. PubMed ID: 2891499
    [No Abstract] [Full Text] [Related]

  • 25. Contrasting regulation by GABA of the displacement of benzodiazepine antagonist binding by benzodiazepine agonists and purines.
    Skerritt JH, Davies LP, Chow SC, Johnston GA.
    Neurosci Lett; 1982 Oct 08; 32(2):169-74. PubMed ID: 6128704
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs.
    Hutchinson MA, Smith PF, Darlington CL.
    Prog Neurobiol; 1996 May 08; 49(1):73-97. PubMed ID: 8817699
    [Abstract] [Full Text] [Related]

  • 30. An in vitro binding assay which differentiates benzodiazepine 'agonists' and 'antagonists'.
    Skolnick P, Schweri MM, Williams EF, Moncada VY, Paul SM.
    Eur J Pharmacol; 1982 Feb 19; 78(1):133-6. PubMed ID: 6122583
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mechanism of action of the benzodiazepines: behavioral aspect.
    Sepinwall J, Cook L.
    Fed Proc; 1980 Oct 19; 39(12):3024-31. PubMed ID: 7418882
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics: a hypothetical allosteric model of the benzodiazepine receptor complex.
    Williams M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1984 Oct 19; 8(2):209-47. PubMed ID: 6146163
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety.
    Lippa AS, Coupet J, Greenblatt EN, Klepner CA, Beer B.
    Pharmacol Biochem Behav; 1979 Jul 19; 11(1):99-106. PubMed ID: 40260
    [Abstract] [Full Text] [Related]

  • 38. Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines.
    Lelas S, Spealman RD, Rowlett JK.
    Exp Clin Psychopharmacol; 2000 Aug 19; 8(3):294-311. PubMed ID: 10975618
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD, Honoré T, Iversen SD, Kemp JA, Knight AR, Marshall GR, Rupniak NM, Singh L, Tye S, Watjen F.
    Br J Pharmacol; 1990 Nov 19; 101(3):753-61. PubMed ID: 1963808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.